La-Z-Boy Q4 Profit Rises, Stock Up 10%

La-Z-Boy Inc. (LZB) Tuesday reported fourth-quarter profit of $57.5 million or $1.33 per share, up from $37.5 million or $0.81 per share last year.

On an adjusted basis, earnings were $1.07 per share, up from $0.87 per share last year. Analysts polled by Thomson Reuters expected earnings of $0.92 per share.

Sales for the quarter increased 32% to $684.6 million from $519.5 million last year. Analysts had a consensus revenue estimate of $664.91 million for the quarter.

Looking forward to the first quarter, the company expects sales of $560 million to $575 million and adjusted operating margin of 6.5% to 7.5%. Analysts currently estimate revenues of $554.19 milion.

LZB closed Tuesday's trading at $22.73, down $0.46 or 1.98%, on the NYSE. The stock, however, gained $2.37 or 10.43% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration announced the intended availability of base powder to make around 6 million bottles of specialty formula from Mexico as part of its efforts to meet the nationwide supply shortage caused by Abbott Nutrition recall. Reckitt Nutrition/Mead Johnson Nutrition will send an initial shipment of 331 thousand pounds of base powder for PurAmino Hypoallergenic Formula. Shares of Deutsche Telekom AG were gaining more than 1 percent in the morning trading in Germany after the telecom major on Thursday raised its fiscal 2022 earnings outlook again, despite reporting lower profit in its second quarter. Adjusted EBITDA AL, a key earnings metric, increased, while adjusted EBITDA AL margin dropped. Lyons Magnus LLC has expanded its initial recall of nutritional and beverage products to include additional brands and code dates, the U.S. Food and Drug Administration announced. The products were recalled due to the potential for microbial contamination, including from the organisms Cronobacter sakazakii and Clostridium botulinum.
Follow RTT